Egypt EDA Medical Device Registration & MeDevice Portal Consultant

Navigate Egypt's EDA regulatory framework with confidence. NexorTest Technologies provides end-to-end medical device registration consulting — from device classification and Egyptian Registration Holder appointment through MeDevice portal submission and import permit management — for Class I through Class III devices, IVDs, and SaMD.

Free Egypt Assessment

Get a personalised regulatory roadmap in 24 hours

Full Name *

Business Email *

Device Class *

Manufacturer Type *

No obligation. Response within 24 hours.

EDA Classification Pathways

Four Risk-Based Device Classes Under Law 151/2019

EDA classifies all medical devices into four risk categories aligned with the GHTF and EU MDR frameworks. Your device class determines the registration pathway, documentation requirements, and review timeline.

Class I — Low Risk

Class I Devices

Lowest-risk devices including non-sterile bandages, tongue depressors, manual wheelchairs, and basic examination instruments. Subject to simplified notification through the MeDevice portal.

How is Class I registration different?

Class I devices follow a simplified notification pathway on the MeDevice platform. While documentation requirements are lighter, evidence of approval in at least one of EDA’s five reference markets (EU, US, Canada, Japan, Australia) is still required for imported devices.

Class IIa — Low-Moderate Risk

Class IIa Devices

Low-moderate risk devices such as diagnostic ultrasound systems, hearing aids, surgical gloves, and blood administration sets. Requires full EDA registration with technical file review.

What documentation is needed for Class IIa?

Class IIa devices require a complete technical file including CE/FDA approval evidence, ISO 13485 certificate, risk analysis (ISO 14971), performance data, biocompatibility assessment where applicable, and Arabic plus English labeling.

Class IIb — Moderate-High Risk

Class IIb Devices

Moderate-high risk devices including ventilators, infusion pumps, condoms, and dialysis equipment. Requires full registration with clinical evaluation and detailed safety evidence.

Is clinical data required for Class IIb?

Yes. Class IIb devices require a clinical evaluation report demonstrating safety and performance. This may include literature-based clinical evaluation, clinical investigation data, or a combination of both, depending on device novelty and intended use.

Class III — Highest Risk

Class III Devices

Highest-risk devices including pacemakers, heart valves, drug-eluting stents, and total joint replacements. Subject to the most stringent EDA review with comprehensive clinical evidence requirements.

What makes Class III review more rigorous?

Class III devices undergo the most stringent EDA review, requiring comprehensive clinical evaluation reports, extensive safety and performance data, post-market clinical follow-up plans, and may require review by EDA’s specialist advisory committees before marketing authorization is granted.

Our EDA Services

Comprehensive EDA Registration Services

From initial classification through post-market surveillance, NexorTest manages every aspect of your EDA regulatory journey in Egypt.

EDA Device Registration

End-to-end medical device registration under Law 151/2019. Complete MeDevice portal submission management, EDA technical review coordination, and acquisition of 10-year marketing authorization for all device classes from Class I through Class III.

Egyptian Registration Holder (ERH)

Appointment and ongoing management of your local Egyptian Registration Holder — whether a licensed distributor, scientific office, or subsidiary. Your ERH handles all EDA dealings, MeDevice submissions, post-market surveillance, and vigilance reporting.

MeDevice Portal Management

Expert navigation of EDA's mandatory electronic platform for all regulatory interactions. We manage device registration submissions, import permit approvals, customs release coordination, amendments, and annual import plan filings through the MeDevice system.

CE/FDA Recognition Pathway

Leveraging Egypt's recognition of five reference markets (EU, US, Canada, Japan, Australia) for streamlined registration. We optimize the fast-track pathway introduced in 2025 for CE-marked and FDA-cleared devices, significantly reducing review timelines and documentation burden.

ISO 13485 QMS Implementation

Mandatory Quality Management System certification for all device classes. We provide gap analysis against ISO 13485 requirements, documentation development, internal audit support, and coordination with accredited certification bodies to achieve and maintain QMS compliance.

Clinical Evaluation Reports

Clinical evaluation scaling with risk class as required by EDA. Literature-based clinical evaluation reports for lower-risk classes, clinical investigation data compilation for Class IIb and Class III, and post-market clinical follow-up plan development.

IVD Registration Egypt

Specialized In Vitro Diagnostic device registration covering IVD classification (Class A through D, aligned with EU IVDR), performance evaluation documentation, MeDevice portal submission, and compliance with EDA's phased registration timeline requirements for all IVD categories.

Import Permit & Customs Management

Complete import lifecycle management including Importation Record setup, per-shipment import permit applications via MeDevice (approximately 6-8 weeks processing), customs release coordination with Egyptian Customs Authority, and annual import planning and forecasting.

Post-Market Surveillance & Vigilance

Comprehensive PMS system setup for the Egyptian market. Includes adverse event reporting for Egypt-only incidents, CAPA management, field safety corrective actions, recall management coordinated through your ERH, and ongoing regulatory compliance monitoring with EDA.

Why NexorTest

Your Trusted Egypt EDA Specialist

We combine deep Egypt and MENA regulatory expertise with global experience to deliver faster, more predictable EDA approvals.

Egypt & MENA Regulatory Specialists

Deep expertise in the EDA framework, Arabic regulatory documentation, and Egypt's recognition of international approvals from five reference markets (EU, US, Canada, Japan, Australia). We understand EDA's processes from the inside.

Design + Testing + Certification Under One Roof

Integrated services covering product design review, safety and performance testing at our own accredited labs, and complete regulatory certification — eliminating multi-vendor complexity and accelerating time to market.

MeDevice Portal & Import Specialists

Experienced with EDA's electronic platform for registration, import approvals, and customs release. We manage the complex per-shipment import permit process, annual import planning, and all MeDevice portal interactions on your behalf.

Multi-Region Regulatory Expertise

Simultaneous registrations across EDA, SFDA Saudi Arabia, CDSCO India, US FDA, EU MDR/CE, and 40+ markets worldwide. One partner for global market access from a single integrated program.

Transparent Pricing & Fixed-Fee Packages

No hidden costs or hourly billing surprises. Our fixed-fee packages cover the complete scope from strategy through marketing authorization, with clear milestones and deliverables at every stage.

First Submission Acceptance

0 %

Countries Served

0 +

Faster Than Industry Average

0 %

Our Process

Six Steps to Your EDA Marketing Authorization

A proven, structured approach that minimizes review queries and accelerates your path to the Egyptian medical device market.

Device Classification & Regulatory Strategy

We classify your device per EDA’s GHTF/EU MDR-aligned system (Class I, IIa, IIb, or III) or leverage EDA’s AI-powered classification tool on the portal. We determine whether the standard or fast-track pathway applies based on your existing CE/FDA approvals and develop a tailored regulatory strategy.

Egyptian Registration Holder Appointment

We appoint an EDA-licensed Egyptian Registration Holder (ERH) — whether a licensed distributor, scientific office, or local subsidiary. We establish the Importation Record on the MeDevice platform with complete manufacturer and device details to enable the registration process.

Documentation & Technical File Preparation

Our team prepares the complete registration dossier including ISO 13485 certificate, CE/FDA approval evidence, Free Sale Certificate, clinical evaluation report, risk analysis (ISO 14971), performance data, and Arabic plus English labeling documentation per EDA requirements.

MeDevice Portal Submission

We submit the registration application via EDA’s mandatory MeDevice electronic platform. EDA conducts a preliminary review within 3-5 working days for sterile device submissions and approximately 3 weeks for general medical devices, verifying completeness before full technical review.

EDA Technical Review & Query Resolution

We manage the full dossier review by EDA’s Central Administration of Medical Devices. Our team promptly responds to all clarification requests, provides supplementary data as needed, and coordinates with EDA reviewers to maintain review momentum and minimize delays.

Marketing Authorization & Import Permit Management

Upon approval, we obtain your 10-year marketing authorization, set up the import permit workflow (approximately 6-8 weeks per shipment), coordinate annual import planning, and establish post-market surveillance and vigilance reporting systems through your ERH.

Industries We Serve

CDSCO Registration Across All Device Sectors

NexorTest supports medical device manufacturers across every therapeutic area and technology vertical entering the Indian market.

🏥 Cardiovascular Devices
🦴 Orthopaedic Implants
🔬 In Vitro Diagnostics (IVD)
💻 Software as Medical Device (SaMD)
🧬 Dental Devices
👁 Ophthalmic Devices
🩺 Patient Monitoring Systems
💉 Drug Delivery Devices
🧠 Neurological Devices
❤ Wound Care Products
🏋 Rehabilitation Equipment
💡 AI/ML-Based Medical Devices
🩸 Blood Bank Equipment
📊 Imaging & Radiology Devices
🧪 Laboratory Instruments
🛡 Sterilization Equipment

Frequently Asked Questions

EDA Registration FAQ

Expert answers to the most common questions about medical device registration with EDA Egypt.

What is EDA medical device registration in Egypt?

The Egyptian Drug Authority (EDA / الهيئة المصرية للدواء) was established by Law No. 151/2019 on 26 February 2020 as the sole regulatory authority governing medical devices, pharmaceuticals, and biological products in Egypt. EDA consolidated the former CAPA, NODCAR, and NORCB under a single entity reporting directly to the Prime Minister’s office. All medical devices manufactured in or imported into Egypt must be registered through the mandatory MeDevice electronic platform. Registration results in a marketing authorization valid for 10 years. Egypt achieved WHO Maturity Level 3 in December 2024, reflecting the strengthened regulatory framework under EDA.

Does Egypt recognize CE marking and FDA clearance?

Yes, Egypt recognizes five reference markets for medical device approvals: the European Union (CE marking), United States FDA, Health Canada, Japan PMDA, and Australia TGA. Evidence of approval in at least one reference market is required for imported devices. In 2025, EDA introduced a fast-track pathway that leverages existing CE marking or FDA clearance/approval to streamline the registration process, significantly reducing review timelines for devices already approved in these reference markets. NexorTest helps manufacturers maximize the benefit of their existing international approvals when entering Egypt.

What is the MeDevice electronic platform?

MeDevice is EDA’s mandatory electronic platform for all medical device regulatory submissions, launched in July 2021. It replaced the former paper-based submission processes entirely. MeDevice handles device registration applications, import permit approvals, customs release coordination, amendments to existing registrations, and annual import plan filings. All manufacturers and Egyptian Registration Holders must use MeDevice for their regulatory interactions with EDA’s Central Administration of Medical Devices. The platform also features an AI-powered classification tool to assist with device classification.

What is an Egyptian Registration Holder (ERH)?

An Egyptian Registration Holder (ERH) is a mandatory local representative for foreign medical device manufacturers seeking to market their products in Egypt. The ERH can be a licensed distributor, scientific office, or a local subsidiary of the foreign manufacturer. The ERH is legally responsible for all dealings with EDA including MeDevice portal submissions, post-market surveillance activities, vigilance and adverse event reporting, and coordinating any recalls or field safety corrective actions. Foreign manufacturers must appoint an EDA-licensed ERH before initiating the registration process. NexorTest assists with ERH identification, appointment, and ongoing management.

How are medical devices classified in Egypt?

Egypt uses a four-tier risk-based classification system aligned with the GHTF and EU MDR frameworks. Class I covers low-risk devices such as non-sterile bandages and manual wheelchairs. Class IIa covers low-moderate risk devices like diagnostic ultrasound and hearing aids. Class IIb includes moderate-high risk devices such as ventilators and infusion pumps. Class III encompasses the highest-risk devices including pacemakers and heart valves. In Vitro Diagnostic (IVD) devices are classified separately into Class A through D, aligned with the EU IVDR classification system. EDA offers an AI-powered classification tool on the MeDevice portal to assist manufacturers in determining the correct classification.

How long does EDA registration take?

EDA registration timelines vary by device class and pathway. Standard registration takes 4-9 months according to EDA published timelines, though practical timelines are typically 6-12 months depending on documentation completeness and query cycles. The fast-track pathway introduced in 2025 for CE-marked or FDA-cleared devices can reduce timelines to 3-4 months. For IVDs, initial review is completed within 20 business days. Class I simplified notification takes approximately 3-4 months. EDA preliminary review of sterile device submissions is completed within 3-5 working days. NexorTest helps accelerate timelines by ensuring complete, high-quality submissions that minimize review queries.

What are Egypt's labeling requirements for medical devices?

Egypt requires both Arabic and English labeling for all medical devices. Arabic is the legally binding language in case of any discrepancy between the two versions. For professional-use devices intended exclusively for healthcare facilities, English-only labeling may be acceptable. Consumer and home-use devices must include Arabic labeling as a mandatory requirement. Unique Device Identification (UDI) compliance is required as part of the labeling requirements. All labeling must be submitted as part of the MeDevice registration dossier for EDA review and approval prior to marketing.

Can NexorTest help with IVD and SaMD registration in Egypt?

Yes, NexorTest provides specialized EDA registration services for both In Vitro Diagnostic (IVD) devices and Software as a Medical Device (SaMD). IVDs are classified into Class A through D following EU IVDR alignment, with performance evaluation requirements scaling by risk class. SaMD falls within EDA’s regulatory scope per the Law 151/2019 definition of medical devices. Our services cover IEC 62304 software lifecycle documentation, cybersecurity risk assessments, AI/ML guidance compliance, and complete MeDevice portal submissions for both IVD and SaMD categories. We manage the phased registration timelines for IVDs and navigate EDA’s evolving digital health requirements for SaMD.

Ready to Enter the Egyptian Medical Device Market?

Get a free EDA regulatory assessment from our Egypt medical device registration specialists. Our experts will map your fastest path to market through the MeDevice portal.